Table 1.
Gene name | Consistently up- or downregulated | Ranked Log2FC in MP46 | MP41 vs. NM: Log2FC | MP41 vs. NM: padj | Ranked Log2FC in MP46 | MP46 vs. NM: Log2FC | MP46 vs. NM: padj |
---|---|---|---|---|---|---|---|
HAGLR | up | 1 | 12.16 | 2.44E-63 | 1 | 12.48 | 3.56E-62 |
TRPM2-AS | up | 2 | 12.12 | 9.08E-29 | 14 | 9.33 | 3.29E-17 |
PRAME* | up | 3 | 12.11 | 3.78E-138 | 2 | 11.92 | 1.46E-113 |
MT1M | up | 4 | 11.7 | 1.77E-25 | 16 | 8.93 | 6.35E-15 |
ASB11 | up | 5 | 11.24 | 5.77E-55 | 6 | 10.59 | 3.51E-47 |
KLHL30 | up | 6 | 10.73 | 8.10E-118 | 8 | 10.16 | 9.85E-100 |
NRN1 | up | 7 | 10.56 | 2.21E-19 | 23 | 7.68 | 3.35E-09 |
TRPM2 | up | 8 | 10.44 | 5.56E-16 | 22 | 7.73 | 5.83E-08 |
CCSER1 | up | 9 | 9.98 | 9.12E-53 | 10 | 9.74 | 1.10E-48 |
RASGRP3* | up | 10 | 9.96 | 1.95E-77 | 4 | 10.84 | 5.23E-77 |
HIF3A | up | 11 | 9.46 | 1.41E-57 | 25 | 7.48 | 1.31E-34 |
HOXA9//HOXA10 | up | 12 | 9.45 | 2.59E-87 | 3 | 10.85 | 9.40E-108 |
PAQR5 | up | 13 | 9.38 | 7.74E-33 | 29 | 7.14 | 7.21E-19 |
LMX1B | up | 14 | 9.31 | 3.28E-30 | 19 | 8.09 | 2.54E-22 |
HOXA11 | up | 15 | 9.29 | 8.02E-38 | 9 | 10.1 | 5.99E-42 |
EPHA4 | up | 16 | 9.04 | 7.55E-124 | 18 | 8.1 | 5.07E-90 |
HOXC4//HOXC5//HOXC6 | up | 17 | 8.91 | 1.65E-09 | 21 | 7.75 | 1.82E-06 |
IGLL3P | up | 18 | 8.79 | 4.08E-24 | 12 | 9.59 | 7.85E-26 |
LINC00482 | up | 19 | 8.6 | 2.51E-103 | 36 | 6.4 | 1.90E-49 |
PLCB4* | up | 21 | 8.59 | 1.43E-13 | 7 | 10.28 | 3.01E-16 |
PNLDC1 | up | 22 | 8.56 | 1.19E-99 | 42 | 6.2 | 2.55E-46 |
MAL2 | up | 23 | 8.43 | 3.04E-24 | 5 | 10.6 | 2.43E-32 |
TTC39A | up | 24 | 8.17 | 1.72E-164 | 26 | 7.42 | 2.68E-120 |
SERPINB9P1 | up | 25 | 8.01 | 1.98E-65 | 32 | 6.69 | 2.66E-41 |
LINC01531 | up | 27 | 7.77 | 5.71E-106 | 11 | 9.65 | 9.41E-141 |
RAPGEF4* | up | 28 | 7.71 | 3.11E-39 | 15 | 9.09 | 5.34E-46 |
CACNA2D2 | up | 32 | 7.58 | 6.51E-70 | 43 | 6.09 | 1.45E-38 |
EPHA8 | up | 33 | 7.51 | 6.15E-53 | 24 | 7.52 | 1.83E-48 |
TWIST1 | up | 34 | 7.46 | 2.18E-48 | 20 | 8.01 | 1.59E-52 |
LRRN2 | up | 35 | 7.12 | 1.89E-38 | 46 | 5.93 | 1.01E-22 |
PITX2 | up | 37 | 6.82 | 5.05E-19 | 30 | 6.89 | 1.88E-16 |
CYP26B1 | up | 38 | 6.79 | 1.94E-35 | 17 | 8.34 | 3.88E-49 |
ITGB2 | up | 39 | 6.67 | 7.50E-31 | 27 | 7.37 | 5.36E-32 |
LTK | up | 43 | 6.57 | 1.09E-19 | 33 | 6.55 | 1.25E-16 |
GABRA3 | up | 44 | 6.56 | 2.94E-05 | 41 | 6.21 | 2.80E-04 |
MGAT4A | up | 47 | 6.38 | 3.23E-44 | 50 | 5.71 | 7.25E-30 |
HAS2 | up | 50 | 6.17 | 5.40E-44 | 38 | 6.32 | 8.15E-39 |
ZNF667 | down | 10 | −9.6 | 2.32E-44 | 19 | −8.96 | 1.89E-50 |
GFRA3 | down | 23 | −8.52 | 1.13E-13 | 24 | −8.56 | 1.58E-13 |
ABCA8 | down | 24 | −8.4 | 2.02E-47 | 10 | −9.91 | 3.14E-43 |
SCN1B | down | 25 | −8.31 | 5.38E-97 | 26 | −8.45 | 2.62E-86 |
PMEPA1 | down | 28 | −8.13 | 2.64E-72 | 28 | −8.43 | 1.34E-64 |
FAM19A5 | down | 29 | −8.1 | 1.39E-65 | 3 | −12.13 | 1.92E-49 |
HS3ST1 | down | 36 | −7.56 | 3.29E-21 | 8 | −10.2 | 2.13E-15 |
MGMT | down | 49 | −7.11 | 1.78E-28 | 20 | −8.86 | 7.47E-35 |
Genes found in top 50 overexpressed or underexpressed in both MP41 and MP46 compared to normal uveal melanocytes. Genes are ranked by log2 fold changes for each comparison.
Genes previously identified in UM studies are indicated with.